Andere Sprachen Mersana Therapeutics, Inc.

Aktien

A2DTR7

US59045L1061

MRSN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
2,94 ^USD	+3,16 %		-9,54 %	+26,72 %

19.03.	MERSANA THERAPEUTICS, INC. : Von JPMorgan Chase auf Neutral hochgestuft	ZM
29.02.	MERSANA THERAPEUTICS, INC. : Von Truist Securities zum Kauf angehoben	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	04.04.
North American Morning Briefing : Markets on Hold -2-	20.03.
Mersana Therapeutics, Inc.(NasdaqGS:MRSN) added to S&P Biotechnology Select Industry Index	18.03.
Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q4 Revenue $10.7M, vs. Street Est of $14.8M	28.02.
Mersana Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results	28.02.
Mersana Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.02.
Mersana Therapeutics to Present at Upcoming Investor Conferences	27.02.
Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024	21.02.
Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference	01.02.
Mersana Therapeutics Gears Up for Milestones in Cancer Drug Trials	05.01.
Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference	05.01.
Mersana Therapeutics, Inc. Announces Business Updates	05.01.
Mersana Therapeutics : Termination of Material Agreement - Form 8-K	21.12.
Mersana Therapeutics, Inc.(NasdaqGS:MRSN) dropped from NASDAQ Biotechnology Index	15.12.
North American Morning Briefing : China Outlook -2-	05.12.
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	01.12.
Mersana Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07.11.
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results	07.11.
Dynamic Innovators: Nano-Cap Stock Watchlist (SING, LILM, OMQS, MRSN)	01.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Mersana Therapeutics, Inc.

Aktien

A2DTR7

US59045L1061

MRSN

Andere Sprachen

Filter